Surface engineering of macrophages with nanoparticles to generate a cell–nanoparticle hybrid vehicle for hypoxia-targeted drug delivery
Christopher A Holden1, Quan Yuan1, W Andrew Yeudall2,3, Deborah A Lebman3,4, Hu Yang11Department of Biomedical Engineering, School of Engineering, 2Philips Institute of Oral and Craniofacial Molecular Biology, School of Dentistry, 3Massey Cancer Center, 4Department of Microbiology and Immunology, Sc...
Guardado en:
Autores principales: | Christopher A Holden, Quan Yuan, W Andrew Yeudall, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/529bedaea4a24837899ea6ce1f7bf0dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preparation and characterization of vinculin-targeted polymer–lipid nanoparticle as intracellular delivery vehicle
por: Wang J, et al.
Publicado: (2012) -
Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
por: Mukherjee A, et al.
Publicado: (2019) -
Local gene delivery via endovascular stents coated with dodecylated chitosan–plasmid DNA nanoparticles
por: Dunwan Zhu, et al.
Publicado: (2010) -
Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
por: Zhang L, et al.
Publicado: (2015) -
Synthesis of biocompatible iron oxide nanoparticles as a drug delivery vehicle
por: Kansara K, et al.
Publicado: (2018)